Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | NADPH cytochrome P450, putative | 0.0031 | 0.0985 | 0.1907 |
Trypanosoma brucei | S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase, putative | 0.0031 | 0.0985 | 0.3033 |
Leishmania major | DNA polymerase kappa, putative,DNA polymerase IV, putative | 0.0019 | 0.0452 | 0.1391 |
Schistosoma mansoni | 5-methyl tetrahydrofolate-homocysteine methyltransferase reductase | 0.0051 | 0.1846 | 0.5684 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.0019 | 0.0452 | 0.0452 |
Schistosoma mansoni | phospholipase D | 0.0049 | 0.1786 | 0.55 |
Brugia malayi | FAD binding domain containing protein | 0.0082 | 0.3247 | 1 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0082 | 0.3247 | 1 |
Echinococcus granulosus | terminal deoxycytidyl transferase rev1 | 0.0019 | 0.0452 | 0.1391 |
Trypanosoma cruzi | Flavodoxin/Radical SAM superfamily/Wyosine base formation, putative | 0.0031 | 0.0985 | 0.3033 |
Echinococcus granulosus | NADPH cytochrome P450 reductase | 0.0082 | 0.3247 | 1 |
Brugia malayi | Phospholipase d protein 1 | 0.0049 | 0.1786 | 0.55 |
Loa Loa (eye worm) | flavodoxin family protein | 0.0031 | 0.0985 | 0.3033 |
Schistosoma mansoni | NADPH flavin oxidoreductase | 0.0041 | 0.1429 | 0.4402 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0019 | 0.0452 | 0.0452 |
Treponema pallidum | flavodoxin | 0.0031 | 0.0985 | 1 |
Echinococcus multilocularis | dna polymerase kappa | 0.0019 | 0.0452 | 0.1391 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0031 | 0.0985 | 0.3997 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0031 | 0.0985 | 0.3997 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0051 | 0.1846 | 0.5684 |
Trichomonas vaginalis | penicillin-binding protein, putative | 0.0036 | 0.1214 | 0.2726 |
Mycobacterium leprae | conserved hypothetical protein | 0.0036 | 0.1214 | 0.5 |
Plasmodium falciparum | NADPH--cytochrome P450 reductase, putative | 0.0031 | 0.0985 | 0.3033 |
Leishmania major | cytochrome P450 reductase, putative | 0.0073 | 0.2831 | 0.8717 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0452 | 0.1391 |
Schistosoma mansoni | rab geranylgeranyl transferase alpha subunit | 0.0019 | 0.0452 | 0.1391 |
Echinococcus granulosus | dna polymerase eta | 0.0019 | 0.0452 | 0.1391 |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.1214 | 0.3738 |
Mycobacterium ulcerans | lipase LipD | 0.0036 | 0.1214 | 0.3738 |
Mycobacterium ulcerans | esterase/lipase LipP | 0.0036 | 0.1214 | 0.3738 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0031 | 0.0985 | 0.3997 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0013 | 0.0182 | 0.0561 |
Plasmodium vivax | hypothetical protein, conserved | 0.0031 | 0.0985 | 0.3033 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0452 | 0.1391 |
Mycobacterium tuberculosis | Probable esterase LipL | 0.0036 | 0.1214 | 0.1214 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0019 | 0.0452 | 0.1391 |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.1214 | 0.3738 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0036 | 0.1214 | 0.3738 |
Leishmania major | hypothetical protein, conserved | 0.0036 | 0.1214 | 0.3738 |
Echinococcus granulosus | methionine synthase reductase | 0.0051 | 0.1846 | 0.5684 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0019 | 0.0452 | 0.1391 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0019 | 0.0452 | 0.1391 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0452 | 0.1391 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.0019 | 0.0452 | 0.1391 |
Plasmodium vivax | NADPH-cytochrome p450 reductase, putative | 0.0082 | 0.3247 | 1 |
Mycobacterium ulcerans | formate dehydrogenase H FdhF | 0.0082 | 0.3247 | 1 |
Entamoeba histolytica | phospholipase D, putative | 0.0049 | 0.1786 | 1 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0082 | 0.3247 | 1 |
Echinococcus multilocularis | methionine synthase reductase | 0.0051 | 0.1846 | 0.5684 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0452 | 0.1391 |
Echinococcus granulosus | phospholipase D | 0.0044 | 0.1529 | 0.4708 |
Loa Loa (eye worm) | ImpB/MucB/SamB family protein | 0.0019 | 0.0452 | 0.1391 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0031 | 0.0985 | 0.3997 |
Brugia malayi | Hypothetical 52.5 kDa protein ZK945.1 in chromosome II, putative | 0.0036 | 0.1214 | 0.3738 |
Trypanosoma cruzi | Flavodoxin/Radical SAM superfamily/Wyosine base formation, putative | 0.0031 | 0.0985 | 0.3033 |
Toxoplasma gondii | ABC1 family protein | 0.0036 | 0.1214 | 0.8661 |
Echinococcus multilocularis | beta LACTamase domain containing family member | 0.0036 | 0.1214 | 0.3738 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0019 | 0.0452 | 0.1391 |
Trichomonas vaginalis | esterase, putative | 0.0036 | 0.1214 | 0.2726 |
Trypanosoma brucei | unspecified product | 0.0013 | 0.0182 | 0.0561 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0036 | 0.1214 | 0.2726 |
Trypanosoma cruzi | p450 reductase, putative | 0.0082 | 0.3247 | 1 |
Schistosoma mansoni | terminal deoxycytidyl transferase | 0.0019 | 0.0452 | 0.1391 |
Echinococcus multilocularis | phospholipase D | 0.0044 | 0.1529 | 0.4708 |
Brugia malayi | Phospholipase D. Active site motif family protein | 0.0017 | 0.0352 | 0.1083 |
Plasmodium falciparum | nitric oxide synthase, putative | 0.0082 | 0.3247 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0013 | 0.0182 | 0.0561 |
Giardia lamblia | DINP protein human, muc B family | 0.0019 | 0.0452 | 0.1596 |
Trypanosoma brucei | NADPH-dependent diflavin oxidoreductase 1 | 0.0082 | 0.3247 | 1 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0082 | 0.3247 | 1 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0036 | 0.1214 | 0.3738 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0036 | 0.1214 | 0.2726 |
Echinococcus multilocularis | terminal deoxycytidyl transferase rev1 | 0.0019 | 0.0452 | 0.1391 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0036 | 0.1214 | 0.3738 |
Mycobacterium tuberculosis | Conserved protein | 0.0036 | 0.1214 | 0.1214 |
Leishmania major | DNA polymerase eta, putative | 0.0019 | 0.0452 | 0.1391 |
Brugia malayi | flavodoxin family protein | 0.0082 | 0.3247 | 1 |
Plasmodium vivax | flavodoxin domain containing protein | 0.0073 | 0.2831 | 0.8717 |
Leishmania major | hypothetical protein, conserved | 0.0031 | 0.0985 | 0.3033 |
Leishmania major | DNA polymerase kappa, putative | 0.0019 | 0.0452 | 0.1391 |
Trichomonas vaginalis | penicillin-binding protein, putative | 0.0036 | 0.1214 | 0.2726 |
Giardia lamblia | Hypothetical protein | 0.0073 | 0.2831 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0082 | 0.3247 | 1 |
Trypanosoma cruzi | cardiolipin synthetase, putative | 0.0017 | 0.0352 | 0.1083 |
Echinococcus granulosus | dna polymerase kappa | 0.0019 | 0.0452 | 0.1391 |
Chlamydia trachomatis | sulfite reductase | 0.0051 | 0.1846 | 1 |
Mycobacterium tuberculosis | Possible conserved lipoprotein LpqK | 0.0036 | 0.1214 | 0.1214 |
Brugia malayi | flavodoxin family protein | 0.0031 | 0.0985 | 0.3033 |
Plasmodium vivax | hypothetical protein, conserved | 0.0036 | 0.1214 | 0.3738 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0013 | 0.0182 | 0.0561 |
Trypanosoma brucei | cardiolipin synthetase, putative | 0.0017 | 0.0352 | 0.1083 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0031 | 0.0985 | 0.3997 |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.1214 | 0.3738 |
Mycobacterium tuberculosis | Conserved protein | 0.0036 | 0.1214 | 0.1214 |
Trypanosoma brucei | unspecified product | 0.0013 | 0.0182 | 0.0561 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0452 | 0.1391 |
Trichomonas vaginalis | NADPH cytochrome P450, putative | 0.0031 | 0.0985 | 0.1907 |
Echinococcus multilocularis | dna polymerase eta | 0.0019 | 0.0452 | 0.1391 |
Schistosoma mansoni | DNA polymerase eta | 0.0019 | 0.0452 | 0.1391 |
Mycobacterium ulcerans | beta-lactamase | 0.0036 | 0.1214 | 0.3738 |
Trichomonas vaginalis | NADPH cytochrome P450, putative | 0.0031 | 0.0985 | 0.1907 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0019 | 0.0452 | 0.1391 |
Mycobacterium ulcerans | fusion of enoyl-CoA hydratase, EchA21 and lipase, LipE | 0.0036 | 0.1214 | 0.3738 |
Plasmodium falciparum | S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase, putative | 0.0031 | 0.0985 | 0.3033 |
Onchocerca volvulus | 0.0036 | 0.1214 | 1 | |
Echinococcus granulosus | beta LACTamase domain containing family member | 0.0036 | 0.1214 | 0.3738 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0452 | 0.1391 |
Echinococcus multilocularis | phospholipase D1 | 0.0049 | 0.1786 | 0.55 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0019 | 0.0452 | 0.1391 |
Mycobacterium ulcerans | hypothetical protein | 0.0036 | 0.1214 | 0.3738 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0036 | 0.1214 | 0.3738 |
Echinococcus granulosus | phospholipase D1 | 0.0049 | 0.1786 | 0.55 |
Leishmania major | p450 reductase, putative | 0.0082 | 0.3247 | 1 |
Trypanosoma cruzi | NADPH-dependent FMN/FAD containing oxidoreductase, putative | 0.0082 | 0.3247 | 1 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0041 | 0.1402 | 1 |
Mycobacterium tuberculosis | Probable conserved lipoprotein | 0.0036 | 0.1214 | 0.1214 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.1018 | 0.3134 |
Brugia malayi | beta-lactamase family protein | 0.0036 | 0.1214 | 0.3738 |
Onchocerca volvulus | 0.0036 | 0.1214 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.1214 | 0.3738 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.1433 | 0.4414 |
Mycobacterium tuberculosis | Conserved protein | 0.0036 | 0.1214 | 0.1214 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0041 | 0.1402 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.1214 | 0.3738 |
Trypanosoma brucei | unspecified product | 0.0019 | 0.0452 | 0.1391 |
Mycobacterium tuberculosis | Probable esterase/lipase LipP | 0.0036 | 0.1214 | 0.1214 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0082 | 0.3247 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0452 | 0.1391 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0452 | 0.1391 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0019 | 0.0452 | 0.1391 |
Brugia malayi | FAD binding domain containing protein | 0.0051 | 0.1846 | 0.5684 |
Mycobacterium tuberculosis | Probable hydrolase | 0.0036 | 0.1214 | 0.1214 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0019 | 0.0452 | 0.1391 |
Onchocerca volvulus | 0.0036 | 0.1214 | 1 | |
Trichomonas vaginalis | NADPH cytochrome P450, putative | 0.0031 | 0.0985 | 0.1907 |
Schistosoma mansoni | diflavin oxidoreductase | 0.0041 | 0.1402 | 0.4316 |
Toxoplasma gondii | phospholipase D active site domain-containing protein | 0.0017 | 0.0352 | 0.2509 |
Trichomonas vaginalis | NADPH fad oxidoreductase, putative | 0.0073 | 0.2831 | 0.851 |
Giardia lamblia | Nitric oxide synthase, inducible | 0.0073 | 0.2831 | 1 |
Entamoeba histolytica | phospholipase D, putative | 0.0049 | 0.1786 | 1 |
Mycobacterium tuberculosis | Probable lipase LipD | 0.0036 | 0.1214 | 0.1214 |
Loa Loa (eye worm) | beta-LACTamase domain containing family member | 0.0036 | 0.1214 | 0.3738 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0036 | 0.1214 | 0.2726 |
Trichomonas vaginalis | sulfite reductase, putative | 0.0082 | 0.3247 | 1 |
Leishmania major | NADPH-cytochrome p450 reductase-like protein | 0.0082 | 0.3247 | 1 |
Brugia malayi | beta-lactamase | 0.0036 | 0.1214 | 0.3738 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0452 | 0.1391 |
Trypanosoma cruzi | NADPH--cytochrome P450 reductase, putative | 0.0031 | 0.0985 | 0.3033 |
Echinococcus granulosus | NADPH dependent diflavin oxidoreductase 1 | 0.0082 | 0.3247 | 1 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0019 | 0.0452 | 0.1391 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0452 | 0.1391 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0082 | 0.3247 | 1 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0036 | 0.1214 | 0.3738 |
Mycobacterium leprae | Probable lipase LipE | 0.0036 | 0.1214 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.1433 | 0.4414 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0019 | 0.0452 | 0.1391 |
Trypanosoma brucei | cardiolipin synthetase | 0.0017 | 0.0352 | 0.1083 |
Brugia malayi | beta-lactamase family protein | 0.0036 | 0.1214 | 0.3738 |
Echinococcus multilocularis | NADPH cytochrome P450 reductase | 0.0082 | 0.3247 | 1 |
Trypanosoma brucei | NADPH-cytochrome p450 reductase, putative | 0.0082 | 0.3247 | 1 |
Trypanosoma cruzi | cardiolipin synthetase, putative | 0.0017 | 0.0352 | 0.1083 |
Schistosoma mansoni | cytochrome P450 reductase | 0.0082 | 0.3247 | 1 |
Mycobacterium tuberculosis | Probable lipase LipE | 0.0036 | 0.1214 | 0.1214 |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.1214 | 0.3738 |
Entamoeba histolytica | phospholipase D active site domain-containing protein | 0.0041 | 0.1433 | 0.7357 |
Loa Loa (eye worm) | beta-lactamase | 0.0036 | 0.1214 | 0.3738 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0019 | 0.0452 | 0.1391 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0452 | 0.1391 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.1018 | 0.3134 |
Echinococcus multilocularis | NADPH dependent diflavin oxidoreductase 1 | 0.0082 | 0.3247 | 1 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0019 | 0.0452 | 0.1391 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.